Showing 1 - 1 results of 1 for search 'Bai Cheng Liu', query time: 0.01s Refine Results
  1. 1
    Post-marketing safety concerns with Tislelizumab: a disproportionality analysis of the FDA adverse event reporting system

    Post-marketing safety concerns with Tislelizumab: a disproportionality analysis of the FDA adverse event reporting system by Chen Li, Chen Li, Yi Ding, Shanshan Cai, Bai Cheng Liu, Xiufeng Wang

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: